Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

6,677 evidence items · page 11 / 268

2 %Three (2%) patients with malaria co-infection and nine (2%) without malaria were hospitalised.

KenyaCOVID-19 · paludismepublished 2026The Lancet. Global healthPubMeddocument of 8 observations

2.61 aHRAsymptomatic infections were associated with an increased 1 month likelihood of symptomatic malaria with an adjusted hazard ratio of 2.61.

Kenyapaludismepublished 2021eLifePubMeddocument of 4 observations

37.3 %The age group most affected with ductal carcinoma was 20–34 years (37.3%).

Kenyaductal carcinomapublished 2023The Pan African medical journalPubMeddocument of 14 observations

17.9 %The prevalence of STIs was 17.9% among Kenyan women aged ≥18 and ≤30 years enrolled in a trial of doxycycline post-exposure prophylaxis.

KenyaSTIsobserved between February 2020 and November 2021published 2023BMC women's healthPubMeddocument of 11 observations

79 %During SLATE II, 79% of patients with ≥1 tuberculosis (TB) symptom were tested for TB.

Kenyatuberculoseobserved SLATE IIpublished 2020BMJ openPubMeddocument of 12 observations

10 %Fewer than 10% of people with hypertension in sub-Saharan Africa are diagnosed, linked to care, and achieve hypertension control.

Kenyahypertension artériellepublished 2022PloS onePubMeddocument of 7 observations

EBV methylation was significantly lower in the malaria group compared to controls in both plasma and saliva (P < .05), indicating increased EBV lytic replication.

Kenyapaludisme · virus Epstein-Barrpublished 2024The Journal of infectious diseasesPubMeddocument of 3 observations

29 %Among 1313 male partners traced, 29% were in the pre-hypertension stage.

Kenyapre-hypertensionpublished 2023MedicinePubMeddocument of 5 observations

21.5 %Submicroscopic infection prevalence was 21.5% (n = 144) in the lakeshore zone in the 2020 rainy season.

Kenyapaludismeobserved 2020 rainy seasonpublished 2022PloS onePubMeddocument of 15 observations

16.4 %Resistance to rifampicin (RIF) among HIV-negative tuberculosis patients in Western Kenya was 16.4%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

31.25 %The prevalence rate of high-risk human papillomavirus (hrHPV) infection among female kidney transplant recipients in Kenyatta National Hospital, Nairobi-Kenya was 31.25% (10 out of 32).

Kenyahigh-risk human papillomavirus (hrHPV) infectionpublished 2022African health sciencesPubMeddocument of 9 observations

38 %P. falciparum PCR-positive prevalence was 38% for Olyset® users among 254 children analysed.

Kenyapaludismepublished 2020Malaria journalPubMeddocument of 6 observations

1 yearCross-subtype neutralizing antibody breadth was detected within a year of superinfection in two individuals.

KenyaVIH/sidapublished 2012PLoS pathogenseurope_pmcdocument of 3 observationsDOI 10.1371/journal.ppat.1002611

2,198 individualsData from 2198 Kenyan children diagnosed with severe malaria were used in the study.

Kenyapaludismepublished 2022Nature communicationsPubMeddocument of 2 observations

28.5 %Resistance to isoniazid (INH) among HIV-negative tuberculosis patients in Western Kenya was 28.5%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

30.3 %Among 396 participants in an HIV incidence cohort in Kenya, 120 (30.3%) had never heard of pre-exposure prophylaxis (PrEP).

KenyaVIH/sidapublished 2024Journal of the International AIDS SocietyPubMeddocument of 6 observations

0.05 relative_risk_ratioSwitching to second-line antiretroviral therapy was associated with lower mortality, with a relative risk ratio less than 0.05 (95% confidence interval: less than 0.05 to 0.1).

KenyaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

Interwave intervals for SARS-CoV-2 infection in coastal Kenya increased from ≤3 months in 2021 to ≥6 months in 2024.

KenyaCOVID-19observed 2021, 2024published 2026Open forum infectious diseaseseurope_pmcdocument of 4 observations

0.12 odds_ratioThose with parasitemia 1–100 p/μL had lower odds of accurate diagnosis (OR = 0.12; 95% CI: 0.05–0.29).

Kenyapaludismepublished 2026Malaria journalPubMeddocument of 10 observations

47.9 %Among older adults living with HIV with hypertension in western Kenya, 47.9% achieved blood pressure control.

Kenyahypertension artériellepublished 2026BMC cardiovascular disordersPubMeddocument of 6 observations

14.1 %Anopheles rivulorum had a Plasmodium falciparum sporozoite rate of 14.1% (9/64).

Kenyapaludismepublished 2022Scientific reportsPubMeddocument of 8 observations

97 %Recent HIV self-testing use was 97% among peer clients as reported by clients.

KenyaVIH/sidapublished 2024Frontiers in public healthPubMeddocument of 7 observations

AFRICOS participants had significantly lower rates of obesity compared to DC Cohort participants.

Kenyaobésitépublished 2022PloS onePubMeddocument of 13 observations

14 %14% of cancer outpatients were underweight, with 25.5% of males and 9.4% of females being underweight.

Kenyacancer (non précisé)published 2018Double Burden of Malnutrition among Cancer Outpatients in Nairobi, Kenya: Challenges and OOpenAlexdocument of 8 observations

18 %The mean difference in Plasmodium falciparum parasite prevalence between rural and urban settlements in East Africa was 18%.

Kenyapaludismepublished 2005Acta tropicaeurope_pmcdocument of 3 observationsDOI 10.1016/j.actatropica.2004.08.010

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.